Roca Oriol, Hernández Gonzalo, Díaz-Lobato Salvador, Carratalá José M, Gutiérrez Rosa M, Masclans Joan R
Critical Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain.
Ciber Enfermedades Respiratorias (Ciberes), Instituto de Salud Carlos III, Madrid, Spain.
Crit Care. 2016 Apr 28;20(1):109. doi: 10.1186/s13054-016-1263-z.
High flow nasal cannula (HFNC) supportive therapy has emerged as a safe, useful therapy in patients with respiratory failure, improving oxygenation and comfort. Recently several clinical trials have analyzed the effectiveness of HFNC therapy in different clinical situations and have reported promising results. Here we review the current knowledge about HFNC therapy, from its mechanisms of action to its effects on outcomes in different clinical situations.
高流量鼻导管(HFNC)支持疗法已成为呼吸衰竭患者一种安全、有效的治疗方法,可改善氧合和舒适度。最近,多项临床试验分析了HFNC疗法在不同临床情况下的有效性,并报告了令人鼓舞的结果。在此,我们回顾一下关于HFNC疗法的现有知识,从其作用机制到在不同临床情况下对治疗结果的影响。